Global EditionASIA 中文双语Français
China
Home / China / Health

Mpox control protocol released

By Zou Shuo | chinadaily.com.cn | Updated: 2023-07-27 17:11
Share
Share - WeChat
[Photo/VCG]

People who are infected with mpox and only have mild symptoms can self-quarantine at their homes, according to the newly released mpox control protocol.

The protocol, issued on Thursday by the National Administration of Disease Prevention and Control and National Health Commission, said when suspected or confirmed cases of mpox are identified, local authorities should transfer them to medical institutions for quarantine and treatment.

If the patients' symptoms improve, they can return to their home for quarantine and their quarantine can end when they fully recover.

During home quarantine the patients should live in separate rooms and should not go to public places, reducing direct contact with family members.

Disease control authorities or medical institutions should call on or visit patients on the seventh, 14th and 21st day.

The patients' close contacts should monitor their health for 21 days.

The protocol said the mpox is mainly transmitted through man-to-man sexual contact and the general public has low risks of infections.

Most people can recover from the disease by themselves, but people with low immunity, such as children and pregnant women can develop severe symptoms or even die from the disease.

Local authorities should report to the public health emergency information management system within two hours after confirmed cases have been found.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US